Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy

Global gene expression profiling is used to generate novel insight into a variety of disease states. Such studies yield a bewildering number of data points, making it a challenge to validate which genes specifically contribute to a disease phenotype. Aerobic exercise training represents a plausible model for identification of molecular mechanisms that cause metabolic‐related changes in human skeletal muscle. We carried out the first transcriptome‐wide characterization of human skeletal muscle responses to 6 wk of supervised aerobic exercise training in 8 sedentary volunteers. Biopsy samples before and after training allowed us to identify ~470 differentially regulated genes using the Affymetrix U95 platform (80 individual hybridization steps). Gene ontology analysis indicated that extracellular matrix and calcium binding gene families were most up‐regulated after training. An electronic reanalysis of a Duchenne muscular dystrophy (DMD) transcript expression dataset allowed us to identify ~90 genes modulated in a nearly identical fashion to that observed in the endurance exercise dataset. Trophoblast noncoding RNA, an interfering RNA species, was the singular exception—being up‐regulated by exercise and down‐regulated in DMD. The common overlap between gene expression datasets may be explained by enhanced α7β1 integrin signaling, and specific genes in this signaling pathway were up‐regulated in both datasets. In contrast to these common features, OXPHOS gene expression is subdued in DMD yet elevated by exercise, indicating that more than one major mechanism must exist in human skeletal muscle to sense activity and therefore regulate gene expression. Exercise training modulated diabetes‐related genes, suggesting our dataset may contain additional and novel gene expression changes relevant for the anti‐diabetic properties of exercise. In conclusion, gene expression profiling after endurance exercise training identified a range of processes responsible for the physiological remodeling of human skeletal muscle tissue, many of which were similarly regulated in DMD. Furthermore, our analysis demonstrates that numerous genes previously suggested as being important for the DMD disease phenotype may principally reflect compensatory integrin signaling.—Timmons, J. A., Larsson, O., Jansson, E., Fischer, H., Gustafsson, T., Greenhaff, P. L., Ridden, J., Rachman, J., Peyrard‐Janvid, M., Wahlestedt, C., Johan, C. Sundberg Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J. 19, 750–760 (2005)

[1]  J. Winer,et al.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. , 1999, Analytical biochemistry.

[2]  Claes Wahlestedt,et al.  Kinetics of Senescence-associated Changes of Gene Expression in an Epithelial, Temperature-sensitive SV40 Large T Antigen Model , 2004, Cancer Research.

[3]  W L Haskell,et al.  Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. , 1988, The New England journal of medicine.

[4]  Eric P Hoffman,et al.  Functional characteristics of dystrophic skeletal muscle: insights from animal models. , 2002, Journal of applied physiology.

[5]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[6]  F. Andreozzi,et al.  PED/PEA‐15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus , 1998, The EMBO journal.

[7]  T. Pawson,et al.  Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient Mice , 2002, The Journal of experimental medicine.

[8]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Manson,et al.  Walking compared with vigorous exercise for the prevention of cardiovascular events in women. , 2002, The New England journal of medicine.

[10]  W. Garvey,et al.  Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. , 1998, Diabetes.

[11]  G. Condorelli,et al.  Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. , 2001, Diabetes.

[12]  M. Pampusch,et al.  Role of insulin‐like growth factor binding protein (IGFBP)‐3 in TGF‐β‐ and GDF‐8 (myostatin)‐induced suppression of proliferation in porcine embryonic myogenic cell cultures , 2003, Journal of cellular physiology.

[13]  N. Inestrosa,et al.  Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation , 2004, Journal of Cell Science.

[14]  C. Sylvén,et al.  Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure , 2001, European journal of heart failure.

[15]  U. Mayer Integrins: Redundant or Important Players in Skeletal Muscle?* , 2003, The Journal of Biological Chemistry.

[16]  M. Rudnicki Marrow to muscle, fission versus fusion , 2003, Nature Medicine.

[17]  P. Carmeliet,et al.  Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. , 2001, Blood.

[18]  A. Geirsson,et al.  Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes. , 2003, Biochemical and biophysical research communications.

[19]  Mei Han,et al.  Gene expression profiling of Duchenne muscular dystrophy skeletal muscle , 2003, Neurogenetics.

[20]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Suuronen,et al.  Type IV collagen and its degradation in paralyzed human muscle: Effect of functional electrical stimulation , 2000, Muscle & nerve.

[22]  E. Sage,et al.  SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF‐dependent signaling , 2003, Journal of cellular biochemistry.

[23]  I. Nonaka,et al.  Transforming growth factor‐β2 is elevated in skeletal muscle disorders , 1999, Muscle & nerve.

[24]  I. Nonaka,et al.  Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. , 1997, Journal of cell science.

[25]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[26]  R S Paffenbarger,et al.  The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.

[27]  J. Carson,et al.  Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle. , 2000, Journal of applied physiology.

[28]  C. Chung,et al.  Involvement of protein phosphatase-1-mediated MARCKS translocation in myogenic differentiation of embryonic muscle cells. , 2002, Journal of cell science.

[29]  S. Goldstein,et al.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.

[30]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Carey,et al.  Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation. , 2002, Journal of cell science.

[32]  Stephen J. Kaufman,et al.  Enhanced Expression of the α7β1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice , 2001, The Journal of cell biology.

[33]  G. Lynch,et al.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. , 2002, The American journal of pathology.

[34]  L. Kunkel,et al.  Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Hoeflich,et al.  IGF-binding protein-5: flexible player in the IGF system and effector on its own. , 2002, The Journal of endocrinology.

[36]  D. Gullberg Cell biology: The molecules that make muscle , 2003, Nature.

[37]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[38]  A. De Luca,et al.  Enhanced Dystrophic Progression in mdx Mice by Exercise and Beneficial Effects of Taurine and Insulin-Like Growth Factor-1 , 2003, Journal of Pharmacology and Experimental Therapeutics.

[39]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[40]  S. Bonner-Weir,et al.  Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2. , 2000, Endocrinology.

[41]  Simon W. Jones,et al.  Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  B. Haendler,et al.  Delineation of the calcineurin‐interacting region of cyclophilin B , 2000, Protein science : a publication of the Protein Society.

[43]  E. Olson,et al.  Calcineurin Signaling and Muscle Remodeling , 2000, Cell.

[44]  F. Booth,et al.  Transcriptional profiling identifies extensive downregulation of extracellular matrix gene expression in sarcopenic rat soleus muscle. , 2003, Physiological genomics.

[45]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[46]  I. Macdonald,et al.  Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise. , 1998, The Journal of clinical investigation.

[47]  D. Górecki,et al.  Developmental and tissue-specific regulation of mouse dystrophin: The embryonic isoform in muscular dystrophy , 1991, Neuromuscular Disorders.

[48]  C. Reggiani,et al.  Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency , 2003, Nature Genetics.

[49]  Eric P. Hoffman,et al.  Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .

[50]  Eric P Hoffman,et al.  A web-accessible complete transcriptome of normal human and DMD muscle , 2002, Neuromuscular Disorders.

[51]  Robert A. Harris,et al.  Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. , 2004, Diabetes.

[52]  W. Kraus,et al.  PGC-1α mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle , 2004 .

[53]  J. Ricort Insulin-like growth factor binding protein (IGFBP) signalling. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[54]  T. Khurana,et al.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions , 2004, Journal of Molecular Medicine.

[55]  C. Kahn,et al.  Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. , 1993, Science.

[56]  H. Vestergaard,et al.  Insulin resistance and maximal oxygen uptake , 2003, Clinical cardiology.

[57]  Andrew P. Weir,et al.  Function and genetics of dystrophin and dystrophin-related proteins in muscle. , 2002, Physiological reviews.